If you ever think of trying out ginseng supplements then also go through possible side effects instead of blindly taking them, said health experts here on Saturday.
According to experts, the popular Chinese herb is linked to bladder cancer.
Ginseng is usually consumed in the form of energy drinks or herbal teas and has been traditionally used to lower blood sugar, cholesterol levels, protect against stress, enhance strength and promote relaxation. Some reports also claim that it has anti-cancer properties.
"The fact that Chinese medications like ginseng cause bladder cancers is clear cut. There are a few cases in India also related to this. The number of bladder cancer cases in China is almost double than anywhere else in the world," urologist and andrologist J.G.Lalmalani, told IANS.
The Mumbai-based expert was talking on the sidelines of an international live/video operative workshop on prostate cancer here at the R.G.Kar Medical College and Hospital in Kolkata.
He said it is best to "study the possible side effects" of such herbal supplements and drinks before regular consumption.
He also cautioned about paying attention to the symptoms of prostate cancer.
"If there is pain while urinating, blood in the urine, sudden weight loss and regular use of bathroom three to four times a night, you must realise something is wrong," he said.
Explaining the increase in the number of prostate cancer cases in India, Lalmalani said an ageing population and heightened detection are the factors behind the numbers.
"Prostate cancer was always present. Now there is ageing population, earlier detection, awareness that prostate cancer exists. Nowadays, people don't opt for ayurveda, homeopathy, get treated and then come late," he said.
"Complementary medicine cannot deal with such major diseases... which are lethal," he said advocating the dictum of early suspicion, prompt diagnosis and a radical treatment.
Worldwide, prostate cancer is the second most common cancer in men. India has seen a steady increase in cases concomitant with an increase in life expectancy.
According to the National Cancer Registry program by the Indian Council of Medical Research, prostate cancer is estimated to go up by 140 percent in the next few years.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
